A carregar...
From threat to cure: understanding of virus-induced cell death leads to highly immunogenic oncolytic influenza viruses
Oncolytic viruses constitute an emerging strategy in immunomodulatory cancer treatment. The first oncolytic virus, Talimogene laherparepvec (T-VEC), based on herpes simplex virus 1 (HSV-1), was approved by the Food and Drug Administration (FDA) and European Medicines Agency (EMA) in 2015. The field...
Na minha lista:
| Publicado no: | Cell Death Discov |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Nature Publishing Group UK
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7288254/ https://ncbi.nlm.nih.gov/pubmed/32542113 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41420-020-0284-1 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|